Literature DB >> 10704887

Pax genes and the differentiation of hormone-producing endocrine cells in the pancreas.

C Dohrmann1, P Gruss, L Lemaire.   

Abstract

Despite the pivotal role of the pancreas in hormonally-regulated pathways in the body, e.g. glucose homeostasis, the genetic mechanisms defining it have for many years remained largely enigmatic. After years out of the spotlight, pancreas development has once again come to centre stage. To a large extent, this is due to recent advances made through the detailed analysis of transgenic mice which have been engineered to carry mutations in specific developmental control genes. This review specifically focuses on the specification of the endocrine pancreas lineage and in particular on the role of the developmental control genes Pax4 and Pax6 in the generation of specific endocrine cell types. The comparison of various phenotypes of different mouse mutants affecting endocrine development supports a model in which Pax4 and Pax6 are required for the differentiation of certain endocrine cell lineages and implies a potential for acting at different levels of endocrine development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704887     DOI: 10.1016/s0925-4773(99)00324-x

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  37 in total

1.  Neurogenin3 triggers beta-cell differentiation of retinoic acid-derived endoderm cells.

Authors:  Amedeo Vetere; Eleonora Marsich; Matteo Di Piazza; Raffaella Koncan; Fulvio Micali; Sergio Paoletti
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

2.  The PAX6 gene is activated by the basic helix-loop-helix transcription factor NeuroD/BETA2.

Authors:  Eleonora Marsich; Amedeo Vetere; Matteo Di Piazza; Gianluca Tell; Sergio Paoletti
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

3.  The beta subunit of voltage-gated Ca2+ channels interacts with and regulates the activity of a novel isoform of Pax6.

Authors:  Yun Zhang; Yoichi Yamada; Mingming Fan; Saroja D Bangaru; Bochao Lin; Jian Yang
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

4.  Functional dissection of the paired domain of Pax6 reveals molecular mechanisms of coordinating neurogenesis and proliferation.

Authors:  Tessa Walcher; Qing Xie; Jian Sun; Martin Irmler; Johannes Beckers; Timucin Öztürk; Dierk Niessing; Anastassia Stoykova; Ales Cvekl; Jovica Ninkovic; Magdalena Götz
Journal:  Development       Date:  2013-03       Impact factor: 6.868

Review 5.  Liver stem cell-derived beta-cell surrogates for treatment of type 1 diabetes.

Authors:  Li-Jun Yang
Journal:  Autoimmun Rev       Date:  2005-12-22       Impact factor: 9.754

Review 6.  A synopsis of factors regulating beta cell development and beta cell mass.

Authors:  Krishna Prasadan; Chiyo Shiota; Xiao Xiangwei; David Ricks; Joseph Fusco; George Gittes
Journal:  Cell Mol Life Sci       Date:  2016-04-22       Impact factor: 9.261

7.  Stem cell therapy to treat diabetes mellitus.

Authors:  Chee Gee Liew; Peter W Andrews
Journal:  Rev Diabet Stud       Date:  2009-02-10

8.  pdx-1 function is specifically required in embryonic beta cells to generate appropriate numbers of endocrine cell types and maintain glucose homeostasis.

Authors:  Maureen Gannon; Elizabeth Tweedie Ables; Laura Crawford; David Lowe; Martin F Offield; Mark A Magnuson; Christopher V E Wright
Journal:  Dev Biol       Date:  2007-11-04       Impact factor: 3.582

9.  Relative roles of the different Pax6 domains for pancreatic alpha cell development.

Authors:  Petra Dames; Ramona Puff; Michaela Weise; Klaus G Parhofer; Burkhard Göke; Magdalena Götz; Jochen Graw; Jack Favor; Andreas Lechner
Journal:  BMC Dev Biol       Date:  2010-04-09       Impact factor: 1.978

10.  Opposing actions of Arx and Pax4 in endocrine pancreas development.

Authors:  Patrick Collombat; Ahmed Mansouri; Jacob Hecksher-Sorensen; Palle Serup; Jens Krull; Gerard Gradwohl; Peter Gruss
Journal:  Genes Dev       Date:  2003-10-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.